Litigation’s always a gamble, and there was no exception for Sidley Austin as it defended Bayer AG in a dispute with the Federal Trade Commission over Bayer’s promotion of its Phillips Colon Health probiotic supplement.
In a two-and-a-half-week bench trial in June, the Sidley team, led by partners Jonathan Cohn and Mark Hopson, challenged the FTC’s claims that Bayer breached the terms of a 2007 consent decree. The decree had required the company to use test results and other evidence to back claims about the benefits of supplements.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
